The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia - Nature.com
- The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia Nature.com
- Experimental Pill Shows Promise Against Leukemia in Early Trial Gizmodo
- Study Unearths Cause of Resistance to New Drug for Acute Leukemia Technology Networks
- Leukemia Drug Trial Reveals How Cancer Cells Resist Therapy Genetic Engineering & Biotechnology News
- Experimental pill achieves complete cancer remission in 18 people with aggressive leukemia EL PAÍS USA
- View Full Coverage on Google News